Revolution Medicines CEO and key executive team

Revolution Medicines's President, Chief Executive Officer and Board Director is Mark A. Goldsmith. Revolution Medicines's key executives include Mark A. Goldsmith and 15 others.
Mark A. Goldsmith

Mark A. Goldsmith

President, Chief Executive Officer and Board Director
Steve Kelsey

Steve Kelsey

President, Research and Development
Luan M. Wilfong

Luan M. Wilfong

Senior Vice President, Human Resources
Xiaolin Wang

Xiaolin Wang

Senior Vice President, Clinical Development
Jack Anders

Jack Anders

Vice President, Finance and Principal Accounting Officer
Zhengping Wang

Zhengping Wang

Vice President, Non-Clinical Development and Clinical Pharmacology
Adrian Gill

Adrian Gill

Vice President, Chemistry
Martin Burke

Martin Burke

Co-Founder and Scientific Advisory Board Chairman
Susan Wilson

Susan Wilson

Vice President, Project and Alliance Management
Michael Fischbach

Michael Fischbach

Co-Founder and Scientific Advisory Board Member
Kevan Shokat

Kevan Shokat

Co-Founder and Scientific Advisory Board Member
Vincent A. Miller

Vincent A. Miller

Chief Medical Officer, Foundation Medicine
Barbara Weber

Barbara Weber

Director
Eric Gordon

Eric Gordon

Senior Advisor and Scientific Advisory Board Member
Mark A. Goldsmith

Mark A. Goldsmith

President, Chief Executive Officer and Board Director
Margaret Horn

Margaret Horn

Chief Operating Officer
Last updated: